John Goldfinch

John Goldfinch is a seasoned professional in the field of clinical operations and project management, currently serving as the US Clinical Lead at TILT Biotherapeutics Ltd since October 2022. Prior roles include Senior Director of Project Management at Nirogy Therapeutics, Director of Clinical Pharmacology Operations at Radius Health, Inc., and various positions at Athenex Pharmaceuticals, where John advanced from Clinical Trials Operation Manager to Director of Clinical Operations. John’s experience also includes coordinating network projects at Roswell Park Cancer Institute. Academic credentials include a Clinical Research Management degree from Duke University, an MBA in Health Care Administration from the University of Phoenix, and a Bachelor of Applied Science in Health and Physical Education from Brock University.